Advertisement

Topics

American Partnership for Eosinophilic Disorders Company Profile

23:14 EST 24th November 2017 | BioPortfolio


News Articles [960 Associated News Articles listed on BioPortfolio]

Fasenra receives FDA approval for severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the FDA has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe ...

Eosinophilic Esophagitis Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Eosinophilic Esophagitis Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Eosinophilic Esophagitis. The key objective of the report is ...

Regeneron, Sanofi Cite Progress in Pursuing Eosinophilic Esophagitis Indication for Dupixent

Regeneron and Sanofi today reported progress toward adding new food allergy indications for their marketed drug Dupixent ® (dupilumab) with announcements of successful Phase II results in adults ...

Fasenra (Benralizumab) receives FDA approval for severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the FDA has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe ...

Eosinophilic esophagitis: update on management and controversies

Eosinophilic esophagitis is a chronic allergen driven immune mediated disease that is increasingly recognized as a leading cause of dysphagia and foregut symptoms in children and adults. Much...

AZ’ Fasenra gets US nod for eosinophilic asthma

AstraZeneca’s biologic Fasenra has picked up its first global approval in the US as a treatment for severe, eosinophilic asthma, a difficult to treat form of the condition.

Endoscopic Dilation for Eosinophilic Oesophagitis

This study assessed the efficacy and safety of endoscopic dilation to alleviate symptoms of stricture formation in eosinophilic esophagitis. Alimentary Pharmacology & Therapeutics

Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis

Targeting IL-5 could improve outcomes and have steroid-sparing effects in the management of eosinophilic granulomatosis with polyangiitis. However, some questions remain about how this approach affect...

PubMed Articles [3225 Associated PubMed Articles listed on BioPortfolio]

Classification of eosinophilic disorders of the small and large intestine.

Eosinophilic gastrointestinal diseases (EGIDs), including eosinophilic gastroenteritis and eosinophilic colitis, have been increasing in prevalence in Western countries in recent years. Eosinophils ar...

Eosinophilic and Non-Eosinophilic Asthma.

Asthma can be subdivided into eosinophilic or non-eosinophilic phenotypes based on the inflammatory cellular patterns seen in sputum, blood, and airway tissue compartments. However, this level of stra...

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis. Mepolizumab, an anti-interleukin-5 monoclonal antibody, reduces blood eosinophil counts and may have value in the treatment...

HISTOLOGICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AND ADOLESCENTS.

Eosinophilic esophagitis is an emerging disease featured by eosinophilic esophageal infiltrate not responsive to proton pump inhibitors.

Long-term outcome of eosinophilic fasciitis: A cross-sectional evaluation of 35 patients.

Eosinophilic fasciitis (EF) is a connective tissue disease with an unknown long-term course.

Clinical Trials [3235 Associated Clinical Trials listed on BioPortfolio]

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of,...

Topical Steroid Treatment for Eosinophilic Esophagitis

A randomized controlled trial of swallowed fluticasone vs. placebo for eosinophilic esophagitis. Treatment will be for 6 weeks with an endoscopy with esophageal biopsies for eosinophilic c...

Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation

A database analysis and review of histological slides (retrospective) and a patient questionnaire analysis (prospective) will be conducted in Bern (Switzerland) to evaluate the efficacy an...

Urban African-American Community Hypertension Control

To investigate whether a health education program, developed in partnership with the community and delivered by nurse supervised community health workers (CHWs), lowered high blood pressur...

An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients

Eosinophils play a key role in the pathogenesis of eosinophilic oesophagitis. Therapies that suppress eosinophil recruitment and activation may give a benefit. Mepolizumab is a humanised...

Companies [2441 Associated Companies listed on BioPortfolio]

American Partnership for Eosinophilic Disorders

Cigna Corporation and Startup America Partnership

The Startup America Partnership is a growing national movement of thousands of founders, experts and resources providing startups access to the corporations, investors, and servic...

Partnership for a Healthier America

The Partnership for a Healthier America is an independent, nonpartisan organization that will mobilize broad-based support for efforts to solve the child obesity challenge. Core a...

Nutricia North America

Nutricia North America, based in Rockville, Md., is a division of Danone. A leader in clinical nutrition, Nutricia North America provides medical foods and infant formulas for the...

The American Association of Clinical Endocrinologists

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinic...

More Information about "American Partnership for Eosinophilic Disorders" on BioPortfolio

We have published hundreds of American Partnership for Eosinophilic Disorders news stories on BioPortfolio along with dozens of American Partnership for Eosinophilic Disorders Clinical Trials and PubMed Articles about American Partnership for Eosinophilic Disorders for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of American Partnership for Eosinophilic Disorders Companies in our database. You can also find out about relevant American Partnership for Eosinophilic Disorders Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record